<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Several small studies have reported an elevated risk of <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> (VT) with <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> and oral contraceptive (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">OCP</z:e>) use </plain></SENT>
<SENT sid="1" pm="."><plain>We aimed to summarize the risk of VT among women with <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">OCP</z:e> use and to assess the interaction between the 2 factors </plain></SENT>
<SENT sid="2" pm="."><plain>We selected 15 studies that assessed the prevalence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">OCP</z:e> use and <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> among reproductive-aged women </plain></SENT>
<SENT sid="3" pm="."><plain>Odds ratios (ORs) were calculated for each study and pooled using the random effects model </plain></SENT>
<SENT sid="4" pm="."><plain>We found an increased risk of VT among women with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">OCP</z:e> use (pooled OR 3.0, 95% confidence interval [CI] 1.9-4.5) and with <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> (pooled OR 4.5, CI 3.4-5.9), respectively </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0001425'>Heterogeneity</z:hpo> was significant (I (2) &gt;80%) </plain></SENT>
<SENT sid="6" pm="."><plain>Women with both <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">OCP</z:e> use had a 14-fold risk of VT compared to healthy <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">OCP</z:e> nonusers (pooled OR 14.25, CI 6.2-32.8) </plain></SENT>
<SENT sid="7" pm="."><plain>Oral contraceptive use and <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> similarly increase VT risk </plain></SENT>
<SENT sid="8" pm="."><plain>Our study confirms an interaction between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">OCP</z:e> use and <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> </plain></SENT>
</text></document>